prikaz prve stranice dokumenta Treatment of hepatocellular carcinoma with liver transplantation : experience at Clinical Hospital Merkur
  Download
PDF 1.46 MB
Professional paper - Conference abstract (invited lecture)
Treatment of hepatocellular carcinoma with liver transplantation : experience at Clinical Hospital Merkur
In: European Surgery / - 3rd Central European Congress of Surgery, Norman Barrett Syndrome. Springer, 2010. pp. 11. urn:nbn:hr:264:493295
Mikulić, Danko; Jadrijević, Stipislav; Škopljanac, Andrija; Kocman, Ivica; Suknaić, Slaven; Mrzljak, Anna; Kocman, Branislav

Cite this document

Mikulić, D., Jadrijević, S., Škopljanac, A., Kocman, I., Suknaić, S., Mrzljak, A. & Kocman, B. (2010). Treatment of hepatocellular carcinoma with liver transplantation : experience at Clinical Hospital Merkur. European Surgery / - 3rd Central European Congress of Surgery, Norman Barrett Syndrome (p. 11). Springer. Retrieved from https://urn.nsk.hr/urn:nbn:hr:264:493295

Mikulić, Danko, et al. "Treatment of hepatocellular carcinoma with liver transplantation : experience at Clinical Hospital Merkur." European Surgery / - 3rd Central European Congress of Surgery, Norman Barrett Syndrome, Springer, 2010, p. 11. https://urn.nsk.hr/urn:nbn:hr:264:493295

Mikulić, Danko, Stipislav Jadrijević, Andrija Škopljanac, Ivica Kocman, Slaven Suknaić, Anna Mrzljak and Branislav Kocman. "Treatment of hepatocellular carcinoma with liver transplantation : experience at Clinical Hospital Merkur." In European Surgery / - 3rd Central European Congress of Surgery, Norman Barrett Syndrome, 11. Springer, 2010. Accessed 2024 April 19. https://urn.nsk.hr/urn:nbn:hr:264:493295

Mikulić, D., et al. (2010) 'Treatment of hepatocellular carcinoma with liver transplantation : experience at Clinical Hospital Merkur', European Surgery / - 3rd Central European Congress of Surgery, Norman Barrett Syndrome, Springer, p. 11. Available at: https://urn.nsk.hr/urn:nbn:hr:264:493295 (Accessed 19 April 2024)

Mikulić D, Jadrijević S, Škopljanac A, Kocman I, Suknaić S, Mrzljak A, and sur.. Treatment of hepatocellular carcinoma with liver transplantation : experience at Clinical Hospital Merkur. European Surgery / - 3rd Central European Congress of Surgery, Norman Barrett Syndrome. Springer; 2010. Pp. 11-11. [cited 2024 April 19] Available at: https://urn.nsk.hr/urn:nbn:hr:264:493295

D. Mikulić, et al., "Treatment of hepatocellular carcinoma with liver transplantation : experience at Clinical Hospital Merkur", European Surgery / - 3rd Central European Congress of Surgery, Norman Barrett Syndrome Springer, 2010. [Online] Available at: https://urn.nsk.hr/urn:nbn:hr:264:493295 [Accessed: 19 April 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Treatment of hepatocellular carcinoma with liver transplantation : experience at Clinical Hospital Merkur
AuthorDanko Mikulić
AuthorStipislav Jadrijević
AuthorAndrija Škopljanac
AuthorIvica Kocman
AuthorSlaven Suknaić
AuthorAnna Mrzljak
AuthorBranislav Kocman
Author's institution(Merkur University Hospital)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Surgery
Abstract (english)
Orthotopic liver transplantation (OLT) is the most efficient option for the treatment of hepatocellular carcinoma(HCC) in terms of survival and recurrence rate provided that restrictive selection criteria are applied. However, tumor recurrence occurs in 3.5–30% of recipients and it has a negative impact on prognosis. In this retrospective study we analyzed survival and tumor recurrence rate in a cohort of patients with HCC treated with OLT in a single center. Between 2005 and 2009 30 patients with HCC were transplanted. Mean age was 58þ5.28 years. Twenty-two patients were male and 8 were female. Etiology was viral in 12 patients (30%), alcoholic in 14 (46.6%) and miscellaneous in 4 patients (13.3%). After a median follow-up of 30.8 months, 25 recipients(83.3%) were alive. Eight patients (26.6%) had disease recurrence. Twenty-one patients (70%) were transplanted within and 9 patients (30%) were outside Milan criteria. A higher recurrence rate was noted in patients surpassing the Milan criteria. OLT is an effective mode of treatment for patients with HCC providing low recurrence rates and survival comparable to liver transplantation for benign disease if restrictive selection criteria are applied.
Keywords (english)
Languageenglish
Publication typeProfessional paper - Conference abstract (invited lecture)
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Publication titleEuropean Surgery / - 3rd Central European Congress of Surgery, Norman Barrett Syndrome
EditionEuropean Surgery
Numberingvol. 42, no. suppl. 235, p. 11
p-ISSN1682-8631
e-ISSN1682-4016
URN:NBNurn:nbn:hr:264:493295
Publication2010
ProjectNumber: 108-1081873-1893
Title (croatian): Prognostički faktori, dijagnostika i terapija hemoblastoza (Jakšić, Branimir, MZOS )
Leader: Branimir jakšić
Jurisdiction: Croatia
Funding stream: zprojekti
ConferenceTitle: 3rd Central European Congress of Surgery, Norman Barret Symposium
Location: Dubrovnik, Croatia
Start date: 2010-04-28
End date: 2010-05-01
Assembly type: Lecture
Document URLhttps://link.springer.com/article/10.1007/s10353-010-0530-5
Type of resourceText
PublisherSpringer
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2023-02-28 11:14:18